Semaglutide is the active ingredient in Ozempic and compounded semaglutide. However, they are two different products.
Ozempic is an FDA-approved medicine made by Novo Nordisk. It comes in standardized doses and has been tested in clinical trials. Compounded semaglutide is a prescription medication that a pharmacy makes from scratch for an individual patient. Its concentration, inactive ingredients, packaging, and instructions can vary.
Knowing the difference between compounded semaglutide vs. Ozempic is important. A compounded product may be designed to work like approved semaglutide, but it has not gone through the same FDA review for safety, effectiveness, quality, or dosing accuracy.
Compounded Semaglutide vs. Ozempic
| Feature | Ozempic | Compounded semaglutide |
|---|---|---|
| Main drug | Semaglutide base | The label may list semaglutide base or another form. |
| FDA approved | Yes | No |
| Manufacturer | Novo Nordisk | A compounding pharmacy or outsourcing facility |
| Formula | Standardized | Varies by pharmacy |
| Available forms | Approved injections and tablets | Commonly vials or prefilled syringes. Some pharmacies offer pills or other forms. |
| Injection schedule | Once weekly | Often once weekly, depending on the prescription |
| Tablet schedule | Once daily | Varies, with limited evidence for compounded oral forms |
| Concentration | Fixed and standardized at 2 mg/3 mL, 4 mg/3 mL, and 8 mg/3 mL for multidose pens or 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, and 1 mg/0.5 mL for single-dose prefilled syringes | May differ between pharmacies and prescriptions |
| Added vitamins | None | Some formulas contain added ingredients, such as vitamin B12, vitamin B6, or niacinamide. |
| Packaging | Approved pens, prefilled syringes, or tablets | Often a multidose vial, syringe, or pharmacy-made capsule |
| Insurance | Covered by some insurance plans | Usually paid for out of pocket |
| Quality review | FDA-reviewed product and manufacturing process | No FDA premarket review of the finished product |
Swipe left or right to view the full comparison.
How is Ozempic made and what does it contain?
Ozempic is a brand-name prescription medicine made of semaglutide. It belongs to a group of medicines called GLP-1 receptor agonists. Novo Nordisk, a Danish pharmaceutical company, makes Ozempic in Bagsværd, Denmark.
What is in Ozempic?
The active ingredient in every approved Ozempic product is semaglutide. The inactive ingredients depend on whether the product is an injection or a tablet.
The full Ozempic ingredients list for the multidose pen formulation contains:
-
- semaglutide
- disodium phosphate dihydrate – helps maintain the proper acidity
- propylene glycol – helps keep ingredients evenly dissolved
- phenol – preservative that limits bacterial growth
- water for injection – sterile liquid that carries ingredients
Ozempic is also available in single-dose prefilled syringes. Those contain semaglutide, disodium phosphate dihydrate, sodium chloride, and water for injection.
Ozempic tablets contain:
-
- semaglutide
- magnesium stearate – a lubricant that helps manufacture tablets
- salcaprozate sodium, also called SNAC – helps the body absorb semaglutide
Is Ozempic a GLP-1 drug or a peptide?
Ozempic is both a GLP-1 drug and a peptide.
GLP-1 stands for glucagon-like peptide-1. Your body naturally releases this hormone after you eat. It helps control blood sugar, affects appetite, and slows how quickly food leaves the stomach. Scientists modified semaglutide so that it lasts much longer inside the body.
What is the Ozempic formula?
The active drug has the molecular formula C187H291N45O59. This semaglutide formula describes the chemical makeup of semaglutide itself.
The peptide backbone of semaglutide is made through yeast fermentation. It is about 94% similar to the natural GLP-1 hormone. The small changes help it attach to a protein in the blood to make it more resistant to breakdown and to help it remain in the body longer.
Despite the common belief that semaglutide contains lizard venom, it does not contain any animal venom. The Gila monster connection comes from exenatide, an older GLP-1 drug.
What is compounded semaglutide?
Compounded semaglutide is a prescription medication that a pharmacy makes from scratch.
The pharmacy starts with a bulk drug ingredient and other materials needed to create the final formula. The pharmacist may place the medicine into a multidose vial, a prefilled syringe, a capsule, or another prescribed form.
Compounding has valid medical uses. For example, a patient may need a different ingredient or dosage form because an approved product cannot meet a specific medical need.
The finished compounded medication does not receive FDA approval. The FDA does not review each compounded formula for safety, effectiveness, quality, or correct strength before the pharmacy dispenses it.
What is in compounded semaglutide?
It depends on the pharmacy and prescription. A formula may contain:
-
- semaglutide base
- sterile water or another liquid
- buffers or preservatives
- additional ingredients like vitamin b12, vitamin b6, niacinamide, glycine, l-carnitine
- other ingredients selected by the pharmacy
The most common form is a semaglutide compound injection supplied in a vial. Some pharmacies dispense prefilled syringes. Other sellers advertise compounded semaglutide pills, capsules, dissolving tablets, drops, nasal sprays, or lozenges.
There are currently no studies that prove that these other semaglutide forms work. Absorption can change greatly when semaglutide is taken as a pill, drop, or spray.
Is compounded semaglutide the same as Ozempic?
No. Ozempic contains semaglutide, but compounded semaglutide is a separately prepared medication.
Ozempic follows a specific FDA-approved formula. Novo Nordisk manufactures it under standardized conditions, and every approved strength has defined ingredients and dosing instructions.
A compounded pharmacy prepares semaglutide for a patient based on a prescription. Different pharmacies may use different concentrations, containers, inactive ingredients, and instructions. Some products also contain vitamins or amino acids.
Differences between compounded semaglutide and Ozempic
The shared word “semaglutide” can make these products appear more alike than they are, but their differences affect reliability, dosing, safety, and cost.
FDA approval
Ozempic has gone through FDA review. This review covers the finished formulation, clinical evidence, labeling, dosing, manufacturing process, and quality controls.
Compounded semaglutide has no FDA approval as a finished product. Not every compounded prescription will cause a problem. But since the FDA doesn’t check the finished formula, the consistency in quality across compounded semaglutide products may be different.
Ingredients
Ozempic contains semaglutide base and a defined list of inactive ingredients.
Compounded formulas vary. One pharmacy may prepare semaglutide base with sterile water. Another may add B12 or niacinamide. Some questionable sellers have also used semaglutide salt or provided incomplete ingredient information.
Novo Nordisk also confirmed that it does not sell semaglutide base to compounding pharmacies. This means compounders get their bulk semaglutide from other sources, so it may differ from the semaglutide used in Ozempic, Wegovy, and Rybelsus.
Manufacturing and quality controls
Injectable medicines must be sterile because they bypass many of the body’s natural defenses. If an injection contains harmful germs or toxins, it can cause a serious infection such as sepsis.
Novo Nordisk makes Ozempic under an FDA-reviewed manufacturing process. The formulation, container, strength, storage conditions, and expiration dating follow approved specifications.
Compounding pharmacies operate under different requirements. State-licensed 503A pharmacies generally prepare patient-specific prescriptions. Registered 503B outsourcing facilities can produce larger batches under additional federal requirements when legal conditions are met.
Doses and concentrations
Ozempic comes in standardized strengths.
-
- Ozempic injection starts at a low weekly dose and may gradually increase according to the approved label and the patient’s treatment needs. The maximum recommended injection dose for blood sugar control is 2 mg once weekly.
-
- Ozempic tablets are taken daily. Current strengths are 1.5 mg, 4 mg, and 9 mg. Tablets and injections are absorbed differently and cannot be compared milligram for milligram.
Compounded injections can have different concentrations. For example, two vials may both say “semaglutide,” but one milliliter may contain a different amount of medicine in each vial.
The FDA has received reports of patients injecting five to 20 times too much compounded semaglutide. In one example, a provider prescribed 20 units instead of 2 units, causing patients to receive 10 times the intended dose and develop nausea and vomiting. Different concentrations, oversized syringes, and unclear instructions can increase the risk of these mistakes.
Injection devices and materials
Approved Ozempic products use standardized devices, including approved pens and certain prefilled syringes.
Compounded semaglutide often comes in a multidose vial, so patients must use an insulin syringe and measure the dose themselves. This can become confusing because the prescription may mention milligrams, the vial may show milligrams per milliliter, and the syringe is marked in units.
In addition, some tested compounded semaglutide products that came in vials or syringes did not adequately protect the medicine from light, air, or moisture. These conditions can cause semaglutide to break down, especially in multidose vials that are repeatedly exposed to air. Certain container materials may also react with the medicine or release substances such as silicone oil into it. These problems could make the dose less stable, less effective, or potentially unsafe.
Approved uses
Ozempic has specific FDA-approved uses supported by clinical studies.
According to the current US prescribing information, FDA-approved uses for Ozempic include:
-
- improving blood sugar control in adults with type 2 diabetes
- reducing the risk of serious cardiovascular events in adults with type 2 diabetes
- reducing certain kidney and cardiovascular risks in adults with type 2 diabetes and chronic kidney disease
On the other hand, compounded semaglutide has no FDA-approved use because compounded drugs are not reviewed or approved by the FDA. A healthcare provider may prescribe it for an individual patient whose medical needs cannot be met by an available FDA-approved medicine. It is not FDA-approved for diabetes or weight loss.
Cost and insurance
The cost of compounded semaglutide versus Ozempic can differ considerably.
Compounded semaglutide injections usually cost about $150 to $400 per month, with many prepaid telehealth plans falling near $200 to $250 monthly. Note that the advertised amount may exclude consultation fees, memberships, laboratory tests, or shipping.
Ozempic’s current list price is $1,027.51 per month, while cash pharmacy prices commonly fall around $900 to $1,100 before discounts. Insurance or savings programs can lower the cost of Ozempic, while compounded plans are rarely covered.
Is compounded semaglutide as effective as Ozempic?
Research into compounded semaglutide’s effectiveness remains limited.
A 2024 retrospective study showed that commercially manufactured semaglutide, like Ozempic, resulted in more weight loss than compounded semaglutide. Both groups received health coaching and followed the same semaglutide titration schedule.
Results After About Four Months
| Result | Commercially manufactured semaglutide | Compounded semaglutide |
|---|---|---|
| Average weight loss | 9.87% | 9.11% |
| Patients who lost at least 10% | 50.5% | 44.6% |
| Patients who lost at least 15% | 21.4% | 12.8% |
The compounded product in this study was prepared under Australian pharmacy standards and underwent independent testing. Each pharmacy can prepare a different formula, so results from one carefully tested product cannot be applied to every compounded product sold in the United States.
Is compounded semaglutide safe?
As of May 31, 2026, the FDA had received 990 adverse-event reports associated with compounded semaglutide.
A properly prepared compounded semaglutide may be safe and appropriate for a patient with a medical need that an approved product cannot meet. However, it still carries more uncertainty because the finished product has not gone through FDA review.
The American Diabetes Association recommends against non-FDA-approved compounded GLP-1 products because of uncertainty about their content, safety, quality, and effectiveness. The organization recommends FDA-approved options when they are available and appropriate.
Frequently Asked Questions
Articles you may also be interested in
